We’re a passionate group of business builders (and pet owners) with backgrounds in life sciences, surgical medicine, microbiology, veterinary medicine, engineering and entrepreneurship. Since launching in 2020, we’ve been on a mission to create a radically better way for clinicians and their patients to access the healing power of the gut microbiome through testing and transplant.
-
Kathleen has over 20 years experience in business consulting and management at Accenture and Point B, followed by senior executive positions in global health and social enterprise organizations. Most recently, Kathleen served as interim CEO at VitalTalk (healthcare) and FIRST Washington (STEM education).
-
Dr. Lendvay is a surgeon, entrepreneur, professor in the Department of Urology at the University of Washington and co-Director of Seattle Children’s Robotic Surgery Center. He was the co-founder and Chief Medical Officer of CSATS (acquired by Johnson & Johnson in 2018). His research and innovation focus on disruptive technologies to improve patient outcomes.
-
Will is an immunologist, microbiome specialist, and microbiologist. Prior to joining Amend Pet, Will was Associate Professor of Medicine at the University of Washington and Director of the DePaolo Lab, a research laboratory working to understand the complex relationship between our immune system and the microbiota in different disease and nutritional states.
